08/08/2025
6:33 PM | Cytosorbents (Issuer)
Sobel Alan D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
6:34 PM | Cytosorbents (Issuer)
Deliargyris Efthymios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
6:35 PM | Capponi Vincent (Reporting)
Cytosorbents (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
6:36 PM | Cytosorbents (Issuer)
Kim Jiny (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
6:37 PM | Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
6:38 PM | BATOR MICHAEL G. (Reporting)
Cytosorbents (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
6:39 PM | Cytosorbents (Issuer)
Jones Edward Raymond (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
6:40 PM | Chan Phillip P. (Reporting)
Cytosorbents (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:06 PM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
4:15 PM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
3:31 PM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CTSO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cytosorbents and its competitors with MarketBeat's FREE daily newsletter. |
05/28/2025
5:47 PM | Avenue Venture Opportunities Fund, L.P. (Filed by)
Cytosorbents (Subject)
| Form SCHEDULE 13G | |
05/01/2025
3:25 PM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
3:28 PM | Cytosorbents (Filer)
| Form DEFA14A | |
04/23/2025
3:31 PM | Cytosorbents (Filer)
| Form ARS | |
04/17/2025
3:05 PM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2025
1:22 PM | Cytosorbents (Subject)
Skylands Capital, LLC (Filed by)
| Form SCHEDULE 13G | |
04/04/2025
6:05 AM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
4:10 PM | Cytosorbents (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
4:12 PM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
6:00 AM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
8:00 PM | BATOR MICHAEL G. (Reporting)
Cytosorbents (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:26 PM | Cytosorbents (Issuer)
Sobel Alan D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:27 PM | Chan Phillip P. (Reporting)
Cytosorbents (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:28 PM | Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:29 PM | Capponi Vincent (Reporting)
Cytosorbents (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:07 AM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
9:22 AM | AVENIR CORP (Filed by)
Cytosorbents (Subject)
| Form SCHEDULE 13G/A | |
01/31/2025
5:49 PM | Cytosorbents (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
01/22/2025
7:29 PM | Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
7:31 PM | Chan Phillip P. (Reporting)
Cytosorbents (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
7:32 PM | Cytosorbents (Issuer)
Sobel Alan D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
7:33 PM | Cytosorbents (Issuer)
Deliargyris Efthymios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
7:34 PM | Capponi Vincent (Reporting)
Cytosorbents (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
7:35 PM | BATOR MICHAEL G. (Reporting)
Cytosorbents (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
8:05 AM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
12:26 PM | Cytosorbents (Subject)
Skylands Capital, LLC (Filed by)
| Form SCHEDULE 13G | |
12/23/2024
3:05 PM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
6:00 AM | Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:00 AM | Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
6:17 AM | Cytosorbents (Filer)
| Form 424B5 | |
The Coin That Could Define Trump’s Crypto Presidency (Ad) When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.” Discover the coin that could define Trump’s crypto presidency. |
12/09/2024
6:18 AM | Cytosorbents (Subject)
| Form FWP | |
12/09/2024
6:08 AM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
8:00 PM | Capponi Vincent (Reporting)
Cytosorbents (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
8:00 PM | Cytosorbents (Issuer)
Deliargyris Efthymios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:25 PM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
4:22 PM | Cytosorbents (Filer)
| Form 424B5 | |
10/01/2024
7:06 AM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
11:15 PM | Cytosorbents (Filer)
| Form EFFECT | |
09/26/2024
4:05 PM | Cytosorbents (Filer)
| Form S-3/A | |
08/20/2024
3:51 PM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
5:57 PM | Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/16/2024
5:58 PM | Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:28 PM | Cytosorbents (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/16/2024
4:12 PM | Cytosorbents (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access